Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

trial   entities : Arrival    save search

DOJ Senior Trial Counsel Amy Kossak Joins Ropes & Gray's Government Enforcement Team
Published: 2024-04-09 (Crawled : 20:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

trial
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2024-02-04 (Crawled : 00:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 0.0% C: -5.78%

liver positive fibrosis bexotegrast trial therapeutics
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Published: 2023-10-11 (Crawled : 17:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 6.48% H: 4.35% C: -5.22%

fda vaccine care trial
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -1.24% H: 0.0% C: 0.0%
PLRX | $12.51 2.63% 2.56% 310K twitter stocktwits trandingview |
Health Technology
| | O: 7.89% H: 11.25% C: 5.98%

liver positive fibrosis bexotegrast trial therapeutics
Treatment of Severe Heart Failure - AI: FineHeart Strengthens Its Management Team in the Run up to the ICOMS FLOWMAKER® First-In-Human Trials
Published: 2022-10-13 (Crawled : 14:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -0.35% H: 0.0% C: 0.0%

flowmaker treatment trials management heart
Enel X and Arrival Partner to Launch Bus Trials in Italy
Published: 2022-06-17 (Crawled : 09:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -4.0% H: 0.0% C: 0.0%

trials trial
ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings
Published: 2022-05-31 (Crawled : 14:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 0.0% C: 0.0%

asco
SEC Regional Trial Counsel Amy Jane Longo Joins Ropes & Gray's Litigation & Enforcement Team as Partner in Los Angeles
Published: 2022-03-21 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -2.14% H: 0.0% C: 0.0%

trial
COVID-19 Changed the Biopharma Industry - and There's No Going Back
Published: 2022-03-09 (Crawled : 06:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 5.73% H: 0.0% C: 0.0%

covid-19 biopharma covid
Industrial Automation Market size worth $ 350 Billion, Globally, by 2028 at 7.8% CAGR: Verified Market Research®
Published: 2022-02-16 (Crawled : 17:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -1.75% H: 5.85% C: 5.09%

research trial market
Arrival begins proving ground trials of its electric Bus
Published: 2021-12-28 (Crawled : 10:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 0.51% H: 6.0% C: 1.79%

als trials trial
Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)
Published: 2021-09-28 (Crawled : 14:15) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -0.59% H: 0.3% C: -2.44%

stroke phase 2 neurological life science
CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up
Published: 2021-09-21 (Crawled : 08:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -0.36% H: 2.24% C: 0.4%

trial
Global Bispecific Antibody Therapeutics Market Forecast Clinical Trials Drug Approval Insight 2028
Published: 2021-08-02 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 0.15% H: 1.54% C: -1.38%

clinical trials antibody drug trial approval
Medable Launches Digital Certification Program to Accelerate Adoption of Decentralized Clinical Trials
Published: 2021-06-24 (Crawled : 16:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 2.11% H: 4.43% C: 1.12%

clinical trials trial
Behind the Wheel: An electrifying partnership – CNH Industrial and Nikola Corporation
Published: 2021-06-17 (Crawled : 11:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -2.32% H: 0.89% C: -2.7%
CNHI | $12.31 -0.73% 0.0% 6.9M twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.06% H: 0.41% C: -2.44%
NKLA | $0.643 -2.58% -2.64% 52M twitter stocktwits trandingview |
Consumer Durables
| | O: 2.03% H: 6.78% C: 5.78%

partnership trial
Eagle Alpha Announces 3 Key Drivers To Industry Excellence - Trial Dataset Delivery, Data Platform Technology and Stronger Partnerships
Published: 2021-05-25 (Crawled : 12:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 0.7% H: 3.3% C: 2.83%

partnership technology liver trial
Gamma Delta T Cell Cancer Immunotherapy Clinical Research Trials Pipeline Outlook 2026
Published: 2021-04-23 (Crawled : 14:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: 3.38% H: 10.07% C: 9.93%

immunotherapy therapy cancer research trial t-cell
Global C5 Complement Inhibitors Drug Market Sales Clinical Trials Opportunity USD 15 Billion 2026
Published: 2021-04-18 (Crawled : 16:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

trial sales clinical trials drug
Global C5 Complement Inhibitor Soliris Ultomiris Market Clinical Trial Research Outlook 2026
Published: 2021-04-18 (Crawled : 16:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

trial research
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.